» Authors » Hiroshi Ishiguro

Hiroshi Ishiguro

Explore the profile of Hiroshi Ishiguro including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 282
Citations 2498
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Furuya K, Hirata H, Kobayashi T, Ishiguro H, Sokabe M
Front Cell Dev Biol . 2025 Jan; 12:1519642. PMID: 39882260
The high interstitial ATP concentration in the cancer microenvironment is a major source of adenosine, which acts as a strong immune suppressor. However, the source of ATP release has not...
2.
Kamide H, Horikawa Y, Sato M, Toyoda A, Sakai K, Minato T, et al.
Front Robot AI . 2025 Jan; 11():1426717. PMID: 39839538
Introduction: This study focused on the psychological evaluation of an avatar robot in two distinct regions, Dubai in the Middle East and Japan in the Far East. Dubai has experienced...
3.
Kodani N, Uchida T, Kameo N, Sakai K, Funayama T, Minato T, et al.
Front Robot AI . 2025 Jan; 11():1469626. PMID: 39835245
After the COVID-19 pandemic, the adoption of distance learning has been accelerated in educational institutions in multiple countries. In addition to using a videoconferencing system with camera images, avatars can...
4.
Uchida T, Kameo N, Ishiguro H
Sci Rep . 2024 Nov; 14(1):29554. PMID: 39609523
This study employs Conversation Analysis to create a recursive model that improves the quality of human-robot interaction. Our research goal is to create a dialogue robot that offers pleasant experiences...
5.
Hagita N, Kanai R, Ishiguro H, Minamizawa K, Arai F, Shimpo F, et al.
Sci Robot . 2024 Nov; 9(96):eadg1842. PMID: 39565866
Cybernetic avatars integrate physical and virtual avatars to enhance human capabilities in diverse scales and contexts.
6.
Nishimura T, Velaga R, Masuda N, Kawaguchi K, Kawaguchi S, Takada M, et al.
Cancer Sci . 2024 Oct; 115(12):3928-3942. PMID: 39375938
Our understanding of neoadjuvant treatment with microtubule inhibitors (MTIs) for triple negative breast cancer (TNBC) remains limited. To advance our understanding of the role of breast cancer driver genes' mutational...
7.
Kawahara H, Kanchi N, Kawata M, Yoshikawa Y, Baba J, Muramatsu T, et al.
PCN Rep . 2024 Sep; 3(3):e70008. PMID: 39253714
Background: Childcare leave extensions can sometimes negatively affect the professional clinical training of early-career psychiatrists in Japan. During childcare leave, being able to learn in the examination room while staying...
8.
Kanchi N, Kawata M, Yoshikawa Y, Baba A, Miyashita T, Ishiguro H, et al.
PCN Rep . 2024 Jul; 3(3):e230. PMID: 39076459
Background: Providing medical care on isolated islands can be challenging in several ways. Telepsychiatry can potentially offer a solution for accessible psychiatric services on isolated islands. When video conferencing is...
9.
Hinata D, Fukuda R, Ishiguro H, Kamada Y, Okiyoneda T
Biochem Biophys Res Commun . 2024 Jul; 733:150433. PMID: 39047427
The most common CFTR mutant in cystic fibrosis (CF), ΔF508 CFTR, is eliminated by ubiquitination even in the presence of CF drugs, reducing their therapeutic efficacy. RFFL is one of...
10.
Iwamoto T, Niikura N, Watanabe K, Takeshita T, Kikawa Y, Kobayashi K, et al.
Breast Cancer Res Treat . 2024 Jun; 208(2):253-262. PMID: 38922548
Purpose: This study aimed to determine whether the 21-Gene Breast Recurrence Score® assay from primary breast tissue predicts the prognosis of patients with hormone receptor-positive and human epidermal growth factor...